- United States
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Li-Cycle Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LICY
NEW YORK, Dec. 09, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers…
Read More » - United States
Agios Presents Positive Results from Phase 2 Portion of the RISE UP Pivotal Study in Sickle Cell Disease at 65th ASH Annual Meeting and Exposition
– Treatment with Mitapivat Demonstrated Statistically Significant Improvement in Hemoglobin Response Compared to Placebo – – Improvements Observed in Annualized…
Read More » - Business Wire
Belgian, Port Houston and Partners Sign Memorandum of Understanding on Energy Transition Cooperation
HOUSTON–(BUSINESS WIRE)–Today, H.E. Alexander De Croo, Prime Minister of Belgium, witnessed the signing of a Memorandum of Understanding on Energy…
Read More » - United States
Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts
BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetes…
Read More » - United States
ROSEN, LEADING INVESTOR COUNSEL, Encourages Expensify, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EXFY
NEW YORK, Dec. 09, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the…
Read More » - United States
FibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in Patients with Anemia of Lower Risk Transfusion-Dependent Myelodysplastic Syndromes at American Society of Hematology Annual Meeting
A post hoc analysis of patients with higher transfusion burden at baseline showed a larger percentage of patients achieved transfusion…
Read More » - Business Wire
Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting
– Orca-T, Orca Bio’s lead investigational high-precision cell therapy, showed similar results in older patients undergoing myeloablative conditioning as seen…
Read More » - United States
FTCH INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Farfetch Limited Investors with Substantial Losses Have Opportunity to Lead Case
SAN DIEGO, Dec. 09, 2023 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of…
Read More » - United States
Cogent Biosciences Announces Positive Initial Data from Phase 2 SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis (NonAdvSM)
Rapid and ongoing improvement in patient symptoms, with 57% median best improvement on MC-QoL and 78% of patients reporting ≥1…
Read More » - Business Wire
LPSN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that LivePerson, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)– If you suffered substantial losses and wish to serve as lead plaintiff of the LivePerson class action…
Read More » - United States
FSR INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Fisker Inc. Investors with Substantial Losses Have Opportunity to Lead Case
SAN DIEGO, Dec. 09, 2023 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that…
Read More » - United States
TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition
No relapses have occurred in six of six treatment-arm patients, four with follow-up past six months; one of four control-arm…
Read More » - United States
Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits
– Data presented at 65th ASH Annual Meeting show CNTY-101 was generally well tolerated at Dose Level 1 (100 million…
Read More » - United States
Corvus Pharmaceuticals Presents New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial
Anti-tumor activity and durability of responses data support advancement of soquelitinib (formerly known as CPI-818) into Phase 3 registrational clinical…
Read More » - United States
X4 Pharmaceuticals Announces Presentation of Additional Data from Mavorixafor Phase 2 Trial in Chronic Neutropenia at ASH 2023
Initial data continue to support advancement of mavorixafor into pivotal, global Phase 3 trial in certain chronic neutropenic disorders; company…
Read More » - United States
Allogene Therapeutics Presents Comprehensive Safety Data of Proprietary Lymphodepletion Agent ALLO-647 at the 65th Annual Meeting of the American Society of Hematology
Comprehensive Review of All Patients in the Phase 1 ALPHA/ALPHA2 Trials Demonstrate that Adding Investigational ALLO-647 to Standard Lymphodepletion Can…
Read More » - Business Wire
Scenic Biotech Announces Positive Preclinical Data for its QPCTL Inhibitor SC-2882 as Potential New Therapeutic Approach for Diffuse Large B-Cell Lymphoma
SC-2882 shows anti-lymphoma and anti-immunosuppression effect in a mouse model for diffuse large B-Cell lymphoma Data presented today, December 9,…
Read More » - United States
NKLA FINAL DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Nikola Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – NKLA
NEW YORK, Dec. 09, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers…
Read More » -
VIDEO: Texas, Florida troopers apprehend more human smugglers in border communities
(The Center Square) – Texas and Florida state troopers, as well as sheriff’s deputies, continue to apprehend human smugglers in…
Read More » - Business Wire
Long-term Follow-up Data From bluebird’s Gene Therapy Program in Sickle Cell Disease Support Durable, Potentially Curative Benefits Through Stable Production of Anti-Sickling Adult Hemoglobin and Resolution of Vaso-Occlusive Events
Oral presentation to include data on 47 patients through five years of follow-up (median 35.5 months, range 0.3-61 months) Endpoints…
Read More » - India
Kerala State Lottery Result: Karunya Lottery No. KR-631st DRAW held on 09-12-2023
KARUNYA LOTTERY NO.KR-631st DRAW held on:- 09/12/2023,3:00 PM AT GORKY BHAVAN, NEAR BAKERY JUNCTION, THIRUVANANTHAPURAM 1st Prize Rs :8000000/- 1)…
Read More » - United States
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSTR, SRC, PATI, GRPH
NEW YORK, Dec. 09, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following…
Read More » -
GrabOn’s CFL 11 and Bachat Wali Diwali Sparkle with Record-Breaking Success
GrabOn, Indias leading online savings destination, is elated to announce the resounding success of its dual-spectacle event - the Cricket…
Read More » -
Texas erects more wire barriers along Rio Grande River as lawsuit continues
(The Center Square) – As Texas’ lawsuit continues against the federal government over its right to defend its border, Texas…
Read More » -
BN Group Undergoes an Identity Makeover; Embarks on Transformation Journey
BN Group, a leading conglomerate with a diverse portfolio of businesses, marked its 10th Foundation Day today with a strategic…
Read More » -
MTR Foods Unveils ‘Minuteverse’ Booth at Comic Con Delhi 2023
MTR Foods, the pioneer in authentic packaged foods introduced its hyper-convenient sub-brand, MTR Minute, to the vibrant audience at Comic…
Read More » - United States
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HA, PFIN, IMGN, SP
NEW YORK, Dec. 09, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following…
Read More » - United States
Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting
Treatment adapted studies show the potential for MRD assessment to guide the personalization of blood cancer care New data demonstrates…
Read More » - United States
MDRX INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Reminds Veradigm Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Dec. 09, 2023 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been…
Read More » - United States
MDRX INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Reminds Veradigm Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Dec. 09, 2023 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been…
Read More »
